The next big thing

Innovation Fields

At the Innovation Center, we are investing in forward-looking ideas. By analyzing current mega-trends, we identify Innovation Fields in which we see potential for new business.

Around the world, healthcare costs have reached all-time highs, the pharmaceutical industry productivity is decreasing and drugs are becoming more expensive. This situation is unsustainable in the long run. Digital technologies have an enormous potential in delivering the needed change: Within our Innovation Field, we aim to decentralize and democratize the healthcare model and empower patients to better manage their health.

Imagine the possibilities!

  • Real-time remote monitoring enabling decentralized healthcare
  • Medical treatment tailored and adaptive to patient condition
  • Measurement of and response to external stimuli and metabolic reactions
  • Decrease of side effects
  • Outcome- and value-based treatments, in which drugs are only reimbursed when the desired patient outcome is achieved


What are we looking for?

  • Bio-sensing modalities that can be used in a decentralized way, such as sensors in patches, VOC sensors, ingestible or implantable sensors and devices for mobiles
  • Data analytics, utilizing the data collected in a regulatory compliant way. Here, we are looking to partner with companies who can help make healthcare data tangible and
    manageable using novel data analytics to extract insights.
  • Actions within our therapeutic areas of expertise, such as autoimmune diseases, neurology, fertility, oncology, cardiovascular health and diabetes.

Our Innovation Field “Clean Meat” – also referred to as cultured, cultivated or cell-basedmeat – focuses on the biotechnology required to produce genuine meat and seafood grown in vitro. This will enable the production of animal protein that is healthier, more ethical and environmentally sustainable. As a leading supplier to the biopharma industry and through our expertise in cell line engineering, culture media and bioprocessing technologies, we aim to become a technology enabling partner for the clean meat industry – from R&D to the efficient scale-up of clean meat production. By working with companies who are looking to commercialize clean meat, we offer our knowledge and production skills to help them to overcome critical technological challenges.

Imagine the possibilities!

  • Eat meat without guilt: clean meat production will use less land and water, generate lesser greenhouse gases and remove animal suffering
  • Better nutrition: Chicken with an extra boost of vitamins, beef enriched with omega-3 or mercury-free tuna


Want to learn more? Have a look at this background story about Clean MeatWhat are we looking for?

  • Technologies to enable economically viable, large-scale production of clean meat and seafood such as animal component-free media, high-yield cell line development, industrial bioreactors or automation platforms
  • Technologies similar to tissue engineering and regenerative medicine, to enable next-generation of structured meat products such as edible scaffolds/biomaterials, 3D cell culture processes or 3D printing

With the recent advent of liquid biopsy as a new sampling and testing method, non-invasive alternatives to traditional tissue-based diagnostics are beginning to be applied more and more in clinical contexts, thereby reshaping the way of detecting and managing various diseases. Our Innovation Field “Liquid Biopsy Technologies” focuses on technological solutions to overcome unresolved challenges in the liquid biopsy workflow as well as on applications beyond cancer.

Imagine the possibilities!

  • Non-invasive diagnosis and patient monitoring
  • Individualized treatment selection in cancer and beyond
  • Detection of diseases early before symptoms appear


What are we looking for?

  • New technologies that help overcome bottlenecks in the liquid biopsy workflow such as the isolation of specific body fluid components or biomarkers
  • Liquid biopsies for indications beyond oncology where existing diagnosis or surveillance methods are inadequate and have significant limitations due to their invasiveness 

Curious to get to know one of our innovation projects within this field? Click here to learn about a novel research use only kit that enables scientists to test out the potential of a biomarker for kidney inflammation monitoring.

Create the NEXT BIG THING with us

We are looking for partnerships to create sustainable new businesses within our Innovation Fields. Interested?

Stay up-to-date!

Click here to subscribe to our e-mail service and get news from our Innovation Center!


You have accessed, but for users from your part of the world, we originally designed the following web presence

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement